The American Society of Regional Anesthesia and Pain Medicine has published a practice advisory on local anesthetic systemic toxicity (LAST) called “Guidelines for the Management of Severe Local ...
Over the last decade, poisonings and deaths linked to the use of local anesthetics have decreased. Even so, poisonings from one commonly used anesthetic, lidocaine, have increased in the United States ...
Our results suggest that ultrasound guidance, HBV infection and the female sex are risk factors of LAST in LPBs and SNBs. For patients infected with HBV or female patients undergoing LPBs and SNBs, ...
If a drug is super potent, the prescribed dose can give you more of the drug than is necessary or safe. With lidocaine, as the Teligent-written, FDA-posted recall notice states, that can lead to ...
For the second time in just over six weeks, Teligent Pharma recalled Lidocaine HCl Topical Solution 4%, 50ml for super potency. This time, instead of just one lot, Teligent pulled five lots, four ...
Deaths from lidocaine poisonings more than doubled since 2010, calls to poison control centers suggested. Calls about local anesthetic poisonings decreased by 23%, mainly due to fewer non-lidocaine ...
Teligent Pharma has voluntarily recalled two lots of Lidocaine HCl Topical Solution USP 4% because testing found it to be “super potent.” People could be using a higher than intended dose of the ...
Inspired by the natural bonding between a class of potent local anesthetics called site-1 sodium channel blockers (S1SCBs) and peptide sequences on the sodium channel in the nerve cell membrane, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results